Vical, Inc. (NASDAQ:VICL)

CAPS Rating: 4 out of 5

The Company researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.

Recs

0
Player Avatar pchop123 (78.31) Submitted: 1/15/2013 3:30:59 PM : Underperform Start Price: $3.56 VICL Score: +8.38

playing the BEAR card on this one

Featured Broker Partners


Advertisement